New Clot-Busting device shows promise for lung blockages
NCT ID NCT05560763
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a device called the FlowTriever2 Catheter in 50 people with acute pulmonary embolism (blood clots in the lungs). The device was used to mechanically remove clots from the lung arteries. Researchers measured safety by tracking serious side effects and effectiveness by checking changes in lung artery pressure. The goal was to see if this approach could quickly improve blood flow and reduce harm from the clots.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- FlowTriever2 Catheter (a device inserted into blood vessels to mechanically remove clots from the lung arteries)
- What this could lead to
- If successful, this device could offer a way to quickly reduce dangerous blood clots in the lungs, potentially improving blood flow and reducing complications.
- What could go wrong
- This was a small, single-arm study with only 50 participants, so results may not apply to everyone. There are risks of bleeding, vessel injury, or worsening symptoms during the procedure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baptist Health
Louisville, Kentucky, 40207, United States
-
Carondelet St. Joseph's Hospital
Tucson, Arizona, 85711, United States
-
Memorial Health University Medical Center
Savannah, Georgia, 31404, United States
-
Oklahoma Heart Institute
Tulsa, Oklahoma, 74104, United States
-
University of Tennessee Medical Center
Knoxville, Tennessee, 37920, United States
-
Virtua Health
Camden, New Jersey, 08103, United States
-
Yale University
New Haven, Connecticut, 06511, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new exercise plan aims to get pulmonary embolism survivors back on their feet
- Spotting hidden blood clots in scarred lungs: a study hunts for clues
- Decades-Long study of 121,700 nurses aims to uncover hidden heart disease triggers
- Massive chest pain registry reveals gaps between guidelines and real-world care in china
- New catheter aims to treat dangerous blood clots in the lungs without ICU stay
- Timing of blood thinners after childbirth bleeding may prevent clots without causing more harm